{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:17:13Z","timestamp":1793902633108,"version":"4.8.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1097\/tp.0000000000003641","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T16:54:00Z","timestamp":1612803240000},"page":"2132-2134","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":31,"title":["Integrating APOL1 Kidney-risk Variant Testing in Live Kidney Donor Evaluation: An Expert Panel Opinion"],"prefix":"10.1097","volume":"105","author":[{"given":"Mona D.","family":"Doshi","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, MI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa J.","family":"Gordon","sequence":"additional","affiliation":[{"name":"Department of Surgery-Transplantation, Northwestern University, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry I.","family":"Freedman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Glover","sequence":"additional","affiliation":[{"name":"Miami, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayme E.","family":"Locke","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Alabama at Birmingham, Birmingham, AL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie P.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Iowa, Iowa City, IA."},{"name":"Department of Medicine, University of Iowa, Iowa City, IA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jama.2013.285141","article-title":"Risk of end-stage renal disease following live kidney donation.","volume":"311","author":"Muzaale","year":"2014","journal-title":"JAMA"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans.","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1056\/NEJMc1800748","article-title":"Worldwide frequencies of APOL1 renal risk variants.","volume":"379","author":"Nadkarni","year":"2018","journal-title":"N Engl J Med"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1526924819892917","article-title":"Variation of ApoL1 testing practices for living kidney donors.","volume":"30","author":"McIntosh","year":"2020","journal-title":"Prog Transplant"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1053\/j.ajkd.2019.02.007","article-title":"APOL1 genetic testing in living kidney transplant donors.","volume":"74","author":"Mohan","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ekir.2019.11.022","article-title":"APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO): design and rationale.","volume":"5","author":"Freedman","year":"2020","journal-title":"Kidney Int Rep"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tem.2016.02.002","article-title":"Apolipoprotein L1 and kidney disease in African Americans.","volume":"27","author":"Friedman","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.2215\/CJN.01330214","article-title":"Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.","volume":"9","author":"Freedman","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/TP.0000000000000969","article-title":"APOL1 genotype and kidney transplantation outcomes from deceased African American donors.","volume":"100","author":"Freedman","year":"2016","journal-title":"Transplantation"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1681\/ASN.2017060658","article-title":"APOL1 genotype and renal function of Black living donors.","volume":"29","author":"Doshi","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/SLA.0000000000002174","article-title":"Apolipoprotein L1 and chronic kidney disease risk in young potential living kidney donors.","volume":"267","author":"Locke","year":"2018","journal-title":"Ann Surg"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1526924818817048","article-title":"A national survey of transplant surgeons and nephrologists on implementing apolipoprotein L1 (APOL1) genetic testing into clinical practice.","volume":"29","author":"Gordon","year":"2019","journal-title":"Prog Transplant"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1053\/j.ajkd.2018.07.017","article-title":"African American living donors\u2019 attitudes about APOL1 genetic testing: a mixed methods study.","volume":"72","author":"Gordon","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/ajt.16206","article-title":"Opinions of African American adults about the use of apolipoprotein L1 (ApoL1) genetic testing in living kidney donation and transplantation.","volume":"21","author":"Berrigan","year":"2021","journal-title":"Am J Transplant"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1681\/ASN.2018111091","article-title":"You are just now telling us about this? African American perspectives of testing for genetic susceptibility to kidney disease.","volume":"30","author":"Umeukeje","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1681\/ASN.2016101084","article-title":"Quantifying postdonation risk of ESRD in living kidney donors.","volume":"28","author":"Massie","year":"2017","journal-title":"J Am Soc Nephrol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003641","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T16:12:27Z","timestamp":1749312747000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003641","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}